Toronto Dominion Bank
OACC

Toronto Dominion Bank’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Toronto Dominion Bank’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.93M Buy
554,294
+57,644
+12% +$614K 0.01% 870
2026
Q1 		$5.25M Sell
496,650
-178,547
-26% -$1.9M 0.01% 836
2025
Q4 		$7.14M Sell
675,197
-258,803
-28% -$2.74M 0.01% 736
2025
Q3 		$9.82M Buy
934,000
+179,022
+24% +$1.87M 0.02% 618
2025
Q2 		$7.89M Buy
754,978
+268,620
+55% +$2.79M 0.01% 647
2025
Q1 		$4.96M Sell
486,358
-950,542
-66% -$9.54M 0.01% 690
2024
Q4 		$14.4M Buy
+1,436,900
New +$14.3M 0.02% 430

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Toronto Dominion Bank's OACC Position: Q2 2026 in Review

Toronto Dominion Bank increased its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 12% in Q2 2026, buying an estimated $614K and bringing the position to 554,294 shares worth $5.93M. The position accounts for 0.01% of the portfolio, ranked #870.

Toronto Dominion Bank first reported a position in OACC in Q4 2024 and has held it in 7 quarters since. The position peaked at $14.4M in Q4 2024. 51 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

  • Toronto Dominion Bank held 554,294 shares of Oaktree Acquisition Corp III Life Sciences worth $5.93M as of Q2 2026.
  • Toronto Dominion Bank bought 57,644 Oaktree Acquisition Corp III Life Sciences shares in Q2 2026, an estimated $614K.
  • Oaktree Acquisition Corp III Life Sciences made up 0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #870 holding.
  • Toronto Dominion Bank first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and has held it in 7 quarters since.
  • Toronto Dominion Bank's Oaktree Acquisition Corp III Life Sciences position peaked at $14.4M in Q4 2024.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.